Company intelligence / Profile preview

Crainio

London, England, United Kingdomcrainio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Crainio is developing a non-invasive medical device for measuring intracranial pressure (ICP), aiming to replace current invasive methods. The company has received grants from Innovate UK Biomedical Catalyst and NIHR FAST programme, and its technology has won several awards. Clinical studies are underway to demonstrate utility and accuracy prior to regulatory approval.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Innovate UK Biomedical Catalyst programmeNIHR FAST programme

Beyond the preview

Go deeper on Crainio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crainio.

Explore the full profile